FTO and nasopharyngeal carcinoma: To further confirm whether ARHGAP35 is downstream of both FTO and ALKBH5, we knocked down both FTO and ARHGAP35 and blocked the expression of ARHGAP35 in NPC cells (Figure S4A–D).